© 2024 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
You don't have any saved screeners yet
Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.
Ladies and gentlemen, thank you for standing by. Welcome to the Sapiens International Corporation's Third Quarter 2019 Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded November 4, 2019.
It is now my pleasure to introduce your Ms. Yaffa Cohen-Ifrah, Sapiens' CMO and Head of Corporate Communications. Thank you Ms. Cohen. You may now begin.
Thank you and good day, everyone. Our quarterly earnings release was issued before the market opened this morning and it has been posted on the company's website at www.sapiens.com. Representing Sapiens today are Roni Al-Dor, President and CEO; and Roni Giladi, our CFO.
Before we start, I would like to remind everyone that this conference call may contain projections or other forward-looking statements and the safe harbor provisions in the press release issued today also apply to the content of the call. Sapiens expressly disclaims any obligation to update or revise any of these forward-looking statements, whether because of future events, new information, a change in its view or expectations, or otherwise.
During the course of today's call, we will refer to non-GAAP financial measures. A reconciliation schedule showing GAAP versus non-GAAP result has been provided in our press release issued before the market opened this morning. A replay of this call will be available after the call on our Investor Relations section of the company website or via the website link, which is available in the earnings release that we published today.
I will turn the call over to Roni Al-Dor, President and CEO of Sapiens. Roni?
Thank you, Yaffa and thank you for joining us today to review our third quarter 2019 financial results. We enter to the second half of 2019 with a strong pipeline of business and our momentum continued to build going into year-end. The outstanding third quarter results demonstrated continued solid execution against our 2019 priorities of top-line growth and margin expansion.
Top-line non-GAAP revenue in Q3, 2019, increased 12.8% year-over-year, primarily due to the expansion in our P&C division and initial growth in our life annuity division. The global focus on our key objective to leverage our offshore capabilities along with improved economics of scale drove a non-GAAP operating margin improvement of 240 basis points versus Q3, 2018. We continue to invest in our North America segment, which is strengthening our pipeline for next year and improving our capability to deliver on current projects.
The outlook for our industry remains robust and we are benefiting from global industry trends that are driving our growth. This include, first and foremost, technology and digitalization, which are the overriding drivers touching all aspects of the insurance industry. Second, consumer expectation for streamlined interfaces and digital access.
As we engage in renewed M&A activity, we are looking to add capabilities, customers and penetrate into new geographies. We are confident that we have the platform to support the long-term top-line growth with infrastructure that can cost-effective scale and support our long-term profitability.
Meanwhile, Sapiens has demonstrated a solid track record of acquisitions that have accelerated top-line growth and improve our margin through both synergies and scales. We have proven our ability to successfully integrate the acquisition and improve the operational performance of the combined entities.
Through our acquisition strategy, we have increased our technology and digital product suite, build customized solutions for our customer and streamlined their offering to their customers and provide digital solutions, analytics and increase our global footprint.
Our recent acquisition of Cálculo, a leading insurance software solutions and services provider for the Spanish market will expand our footprint in Europe. Spain is the 15th largest economy in the world and fifth largest in Europe. Cálculo's team of experts one of the largest insurance systems teams in Spain and their impressive customer base that includes several blue-chip companies will help Sapiens to continue its global expansion. A leading industry research expert Juan Mazzini for Celent see this as a perfect time to enter to the barren market and he anticipated this market will invest in new system in the near future.
This acquisition is a model for our M&A growth strategy on all fronts. It enabled us to expand geographically, grow our customer base and add a talent team of experts as well as complementary capabilities and services for our portfolio. Product innovation is a key differentiator for Sapiens and forms the basic of our appeal to our global customer base, as does our commitment to serve as a one-stop shop for a full set of solutions.
In order to bridge the innovation gap between insurance provider and ensured company, Sapiens continued to expand its ecosystem. During the quarter, we have expanded our solution set with Kovrr a predictive cyber-risk modeling firm that provide global insurance, real-time data driven, insight into the cyber-risk exposure to help them to meet modern regulatory requirements and avoid potentially large policy losses.
Recently, we expanded our partner ecosystem with FRISS, an automated fraud detection and risk assessment leader for P&C insurance industry. Both solutions make innovation insurtech solution easily available to our insurance care customer. I'm happy to share with you that in the report that was published two weeks ago, Sapiens was recognized again a leader in Gartner Magic Quadrants for non-life insurance platform in Europe for Sapiens' IDIT suite.
Gartner stated that one of Sapiens' strength was with our digital division. We established several partnerships with insurtech to include use case of emerging technology, for example machine learning, IoT and blockchain and that the partnerships developed by us will enable insurers to trail the technology more quickly.
Moving to the deal front. In the third quarter, we closed new business in P&C as well as Life Pension. We are to go live and expand our partnership ecosystem. In Europe, we are very pleased to add MSV Life Malta's largest life insurance company to our growing customer base family. MSV Life chose Sapiens to decommission their legacy system and transform their businesses with Sapiens' innovative core suite, which will reduce time to market and costs for future product rollouts.
Our Life & Pension core suite, cloud-based agent Connect and Sapiens' Intelligent Analytics will allow MSV rapidly digitalize and make wholesale change without disrupting their core businesses. Last month, we announced partnership with Atos a global leader in digital transformation with 120,000 employees in 73 countries.
Sapiens' consolidation method will be enhanced by Atos' Innovating Services and Business process outsourcing. This will allow our European customer to manage their legacy portfolio with a wide range of Life & Pension products. By consolidation our services onto one platform, Atos will dramatically reduce cost and increase efficiency. This new partnership already gained U.K. customer for Sapiens' software solution.
This quarter, our customer Dentists' Provident, a leading provider of income protection insurance in U.K. and Ireland successfully deployed our core suite for Life & Pension and implemented our customer connect, with the goals of providing streamlined processing, improve efficiency and enhanced customer services. Sapiens and Dentists' Provident work closely to ensure a smooth migration and implementations.
Another goal life in the quarter was S1 Medical, a firm that provides unique niche programs to casualty market in U.S. with the launch of Sapiens' goal for workers' compensation. This was a busy quarter on the marketing and brand awareness front. Sapiens' team exhibited in the trade shows worldwide, including the African Insurance Exchange in Sun City, InsureTech Connect in Las Vegas, and NAMIC Annual Convention in National Harbor. This year we teamed the Sapiens' Client conference, the art of innovation. In September, we hosted Sapiens Summit 2019, our annual U.S. Client conference. Over 426 participants from approximately 174 organizations attended summit this year. Participants including insurance and financial services customers prospect and as well as industry expert and Insurtech partners. The agenda included strategic discussion, presentation of highlights industry development, and Sapiens' future vision.
On October, we hosted our Global client Conference in Rome. More than 150 participants from approximately 33 organization including insurance and financial services customer and prospects discussed the future of insurance industry trend and Sapiens' strategy and vision.
We anticipate a strong finish to the year with a strong balance sheet and expanding portfolio of product and solution offering to meet the end-to-end needs of our clients. Offshore capability to support our growth and growing global footprint, Sapiens is well-positioned to deliver long-term sustainable growth. I would like to extend my appreciation to the global Sapiens' team for their dedication and passion in their work.
I would now like to turn the call over to our CFO, Roni Giladi to provide more detail on our financial results. Please go ahead Roni.
Thank you Roni. I will begin my commentary with a review of the third quarter non-GAAP results, followed by comments on the balance sheet, cash flow and end with our 2019 revised outlook.
Revenue in the third quarter of 2019 totaled $82.6 million, up 12.8% from the third quarter of 2018. Our revenue in North America, totaled $44.4 million, an increase of 20.9% compared to last year. Revenue in Europe, totaled $30.3 million, a 1.1% decrease compared to last year. Revenue in Europe declined compared to last year due to the impact of customer go-lives and currency impact. The 12.8% revenue growth this quarter represents pure organic growth and was negatively impacted by currency fluctuations. Our P&C segment continues to grow quarter-over-quarter and we start to see initial growth in our Life & Annuity segment in the third quarter.
Moving to gross profit. Gross profit this quarter totaled $36.7 million, compared to $30.9 million in Q3 of last year. Our gross margin this quarter increased to 44.4% from 42.2% in the third quarter of last year. The improvement of 220 basis points compared to last year is mainly due to our offshore operation.
To give an indication, our India delivery offshore doubled in the last year to support our growth. We have demonstrated improvement in both gross profit and gross margin in the last several quarters and plan to continue to improve it in the future.
Moving to operational costs. In the third quarter, we continued our investment in R&D to maintain our product leadership. R&D investments this quarter totaled $11 million as compared to $9.7 million in the same period of last year and $10.5 million in Q2 of 2019.
R&D investment remained approximately 13.3% of total revenue. SG&A expenses totaled $12.2 million, compared to $11 million last year and $11.7 million in the prior quarter. Operating margin improved continuously and totaled $13.5 million this quarter, compared to $10.3 million in Q3 of 2018 and $12.6 million in the prior quarter. This quarter for the first time, we passed the 16% operating margin benchmark and reached record high margin of 16.4%, improvement of 240 basis points compared to last year. While revenue grew this quarter, 12.8% operating profit grew 31.7%, demonstrating our effort to grow in efficient and profitable way.
During the past several quarters all major Sapiens currencies, new Israeli shekel, euro, pound negatively impact our results, while Indian rupee remained stable. Excluding currency impact, our operating margin will be over 17% with currency as of Q3 of last year. Our adjusted EBITDA margin this quarter reached 17.6% compared to 15.3% last year.
Financial expenses this quarter totaled $261,000. The financial expenses this quarter included $630,000 interest expenses on our debenture. That was offset by financial income from hedging transaction to protect our profitability. We do not expect to have this income next quarter.
Tax expenses this quarter increased to $2.8 million, as compared to $1.7 million of last year with effective tax rate of 20.9%. Net income attribute to Sapiens' shareholders for the quarter was $10.4 million or $0.21 per diluted share, compared to $7.5 million or $0.15 per diluted share in the third quarter of last year.
Turning to our balance sheet. As of September 30, 2019, we had cash and cash equivalents of $73.1 million. The balance of our Series B Debenture at the end of the quarter is $68.7 million and will be paid in equal annual installments over the next seven years. Our adjusted free cash flow, which reflects the cash flow generated from ongoing business totaled $16.3 million, compared to adjusted free cash flow of $4.2 million in Q3 of 2018 and $14.6 million in the previous quarter. The increase in adjusted free cash flow is an indication to our continuous improvement in our operational profitability and reduction in diesel.
This quarter we had onetime cash payment of approximately $6.3 million related to our investment in new campus in India. In the last day of the quarter, we completed acquisition of Calculo. While we did not have an impact on the P&L at all our balance sheet included Calculo balance sheet items with an overall minimal impact.
I would like to turn now to our guidance for 2019. Revenue. Looking out to the remainder of the 2019, we anticipate continuing with our organic growth momentum. And following the acquisition of Calculo, we expect to see an increase in revenue due to the first time P&L consolidation. We are increasing our full year 2019 non-GAAP revenue to the range of $323 million to $325 million, compared to previous guidance of the higher end of $318 million to $323 million.
Operating profit. Looking at our Q4 margin, we expect Sapiens' standalone operating margin to improve compared to Q3 2019. However, due to the acquisition of Calculo, our Q4 consolidated margin will be slightly down from Q3 record margin. That being said, we are increasing the guidance for the full year 2019 non-GAAP operating margin to the range of 15.8% to 16% compared to our previous guidance of 15.6% to 15.8%.
On the M&A front, as Roni said earlier, we just completed the acquisition of Cálculo in Spain and started the post-merger integration. We are planning to continue with our effort to find additional companies that fit our strategy, which is geographic expansion, complementary products and customer base. We continue to look for a small to midsized company with revenue in the range of $5 million to $30 million.
In summary, this quarter we reported organic revenue growth of 12.8%, operating margin at the level of 16.4% and a strong adjusted free cash flow of $16.3 million.
I would like now to turn the call back to Roni Al-Dor for closing comments. Roni?
Thank you, Roni. For the remainder of the year, we will continue to focus on growth and margin expansion. This is a quarter of solid operating results in which we execute well against our long-term objective of improved shareholder value.
I would now like to close our prepared remarks and open the call for questions, operator.
Thank you. Ladies and gentlemen, at this time we will begin the question-and-answer session [Operator Instructions] The first question is from Mayank Tandon of Needham & Co. Please go ahead.
Thank you. Congrats on the strong results. So maybe first for Roni Giladi. I was going to just focus on the numbers to start with in terms of your growth rate. So I think looking at the guidance, it comes out about 16% top line growth in the fourth quarter Roni. So I know there's some contribution for the acquisition but how should we think about the growth trajectory going forward, given your pipeline and backlog trends, especially for fiscal 2020?
Hi, Mayank. Thank you for the congrats. We are looking to have the same momentum as we have building our growing P&C presence in U.S.A. and Europe. The same of -- as we mentioned initial start of the Life and Annuity, starting with Europe and moving to the U.S.A. later on.
That being said, we'd like to maintain our overall statement. We'd like to have organic growth of the range of 9% to 11% going forward and on top of that accelerate M&A. Of course, we are trying to achieve more than that but this is what we are looking forward.
Got it. And then given that Europe's been relatively soft. I know there are some -- maybe a one-time factor in terms of customer go-live issue and then you mentioned FX headwinds. But just from a 2020 perspective, how do you think growth shakes out between North America and Europe? Is it going to be more evenly split? Or will it still be heavily skewed towards North America versus Europe?
The European as we mentioned, Mayank, again it's a one-time. We expect to see improvement from the next quarter. It was mainly going live and currency effect. As we mentioned, the pound, euro and also new Israeli shekel that affected us.
Going forward, today we have a stronger pipeline in the States versus Europe. We are seeing right now higher growth in the States than Europe. This is again what we see today.
Got it. And then finally on margins. If I could just ask you about again 2020. I know you're not giving specific guidance. But given the progress you made on the offshoring front and all the leverage that's inherent in the business model, could you talk about the market and expectations for 2020? Even just qualitatively, if you don't want to give any specific numbers at this point.
Yes of course. Our mid-term, two years ago was about 17%. And during this year, we said it will be short to mid-term 17%. This is what we see right now. This is not the guidance but this is what we said earlier. That need to be taken into effect, the acquisition that we have made. Usually acquisition that we are doing impact the margin not the profit, but the margin down. So, we need to take this into factor. So a stand-alone basis, as I mentioned, this is a target to reaching to 17% with some slowdown with the acquisition at least in the first year, which we will reduce it slightly.
Roni just to put you on the spot, can we then think about margins maybe in 2020 get into the upper end of that range that you've guided to the 15% to 17% with the acquisition lapping at the end of next year? But given again some of the levers that you have been putting in place can we expect margins to maybe get closer to 17% versus the 16% that we're modeling for 2019?
Yes. Then the average of close to 17% seems reasonable.
Great. I will get back in queue. Thank you.
Thanks.
The next question is from Bhavan Suri of William Blair. Please go ahead.
Hey, guys. Can you hear me all right?
Yes.
Hi, Bhavan.
Hey, what going on guys? It's Dylan on for Bhavan. I guess, I just wanted to start off with a kind of market-macro perspective have you guys seen any changes? I know you talked about a strong pipeline in North America. But I mean, have you seen any change or acceleration in adoption for these core system solutions in P&C there? And then how have the cloud conversations trended or picked up over the last 12 months?
No, we continue – it's Roni Al-Dor, Bhavan. We continue to see demand in both P&C in Europe and the States. We see a lot of digital interest for this. And it's – we are in a good momentum right now.
Okay. Great. And then I guess just building off of that as well. I know you guys have focused a lot of your initiatives on North America building out a new sales team some sales hires there working on cross-sell initiatives. Can you guys provide any color on how that's gaining traction now that that's maybe six to nine months down the road. And then trending compared to your guys initial expectations?
Again this is – the sales cycle in our business is relatively long 6 to 12 to 18 months. And also we decide to look after a higher tier. So, definitely, we are building our backlog and pipeline, but it also takes time. But we are in the business for many years. So we know, we are also put more effort on the Workers' comp business. So it's a big part of the P&C business. So it's also – it's a big thing, but it also takes time. So the overall, we put all the investments in place. We see – start to see the fruits of the investment. We are also in the same times we built our CC organization dealing with our client base. We did a very successful client conference in this quarter. So, overall positive. But in this business things take time.
Okay. Great. And then one last one for me, if I may just looking at guidance for the remainder of the year, we had about $1 million beat this quarter. And I know, you've mentioned that Calculo is expecting roughly $1 million in revenue for the year, and it sounds like from the higher and maybe a guidance of $2 million to $3 million. What – could you elaborate anymore on the plans kind of what stepped forward driving growth? And then how much of the acquisition played into the guidance raise for the fiscal year? Thank you.
Hi, Dylan. This is Roni Gi. And the Calculo acquisition as we mentioned when we acquired the company this is a company at the level of about $9 million to $10 million revenue not growing at the level of flat. This quarter, we increased the guidance. We continue to grow separately, but we added the additional one quarter or even slightly below one quarter because December is not productive period into the numbers. So altogether, let's say about $2 million. The growth that we expect from this region this plane, we are planning to have this only in the 2022. 2021 will be to build the pipeline in the organization.
Okay. Great. Thanks guys for taking my questions.
Thank you.
Your next question is from Tavy Rosner of Barclays. Please go ahead.
Hi, thanks for taking my questions and congrats on the good results. Just a follow-up question, if I may. I mean you guys mentioned the solid marketing efforts you did with your conferences in the U.S. and Europe. And I guess comparing this year's conference to last year's conference like -- do you feel that there is more interest that i.e. I'm trying to get a sense of your pipeline. You mentioned the long sales cycle, so let's say 18 months from now you feel that we'll be in a much stronger position i.e., things are picking up, insurance companies want to invest more. They want to transform and get your product faster now than they did a year ago?
We are doing as you mentioned a lot of marketing activity. The client conference is mainly to our existing clients. And -- but we are bringing a few prospects from that that they again get the confidence from our existing clients, talk to them, get the confidence and we can see a good results after that. And we have the general conference like the big conference in Vegas and all -- many others that we are doing and definitely it puts us in a good spot. And we are building our branding and -- and the customers and we are also positioned very high in the analyst community. So we see a positive momentum. But again as I mentioned everything takes time.
Yes, I appreciate it. And then your competitors often talk about moving from perpetual to term and cloud. Those are all the sexy names. And I guess, when do you think that Sapiens will be ready to start disclosing? Start breaking it down, cloud revenues? Term versus perpetual? Where are we, are we early stage or -- where are we on that journey?
This is Roni Gi. First of all, we are at -- we are early in this journey, but we are investing in this a lot. You mentioned the cloud. We opened infrastructure to move people on the AWS infrastructure, we are building team in offshore location to be more profitable in that area. These things take time. On the sales side, I can say that all the new deals that we are getting -- all the RFP that we are getting from the States, about 50% of them are cloud requested and we are being able to answer this demand.
Europe is slightly less than this. We are talking about 30% of the new deals that we are signing. So now moving forward with that in full speed; but these things take time and only we are building the new layer. The existing layer is obviously on the different infrastructure.
And as a follow-on to that I mean, let's say, we're not talking about cloud, but even on-prem you would say what percentage of new contracts or at least RFPs are for -- are still for perpetual? Do you still have those or all new contracts are on term loan?
Starting from 2019, we took a management decision that all deal will be on the term license moving from perpetual license. We started it, implemented it. I can say that majority of the deals that we are signing today are term licensed. We will not lose the customer because of that, but we are significantly moving into term.
Perfect. Appreciate. Thank you guys.
Thank you, Tavy.
The next question is from Bryan Bergin of Cowen. Please go ahead.
Hi, thank you. Wanted to ask on the Life & Annuity business, you commented here on initial growth. Can you give us a sense of the scale of that how we should be thinking about growth from here in that product base? And then just can you remind us the scale of that business today?
Hi Bryan. This is Roni Gi. Today the Life & Annuities represent about, I would say 20% of the business, slightly more and we are seeing initial growth. It's not significant, but we see the trend. We talk about in the last two years that this is in the claim mode customers going live and there is no new business coming in. So right now we see initial. It's a small amount right now. But for sure the initial target for this would be stabilization, we may exceed it. So this is number one.
We have mentioned this quarter about two deals. One of them was in U.K., the Atos and the other one was MSV Life. I think two things that on the life side that give us momentum. And also we see a nice pipeline building. By the way also small ones in the States and in Europe to build this growth future. We are not giving guidance for this by vertical, but we're sure we'll see change in the trend.
Okay. Sounds good. And then as far as Europe goes, can you just comment on the outlook there? Really the client-tone and the pace of decision-making? And then I don't know if you scale this, but what was the FX impact whether it's just in Europe or the overall company on revenue?
Yes. The majority of the FX was in Europe few percentage points for the European one, 3% to 4%. Then this with additional going live on the European side. I think we will see from the next quarter increase in the revenue in Europe. We do not see any delay in decision because of the Brexit or things like that. We are very strong today in the U.K. Nordic. We'd like to expand in this region in Europe. I think where we completed Cálculo; this is one area for us for growth. Again as we mentioned we're planning to see growth there in 2022. And as we mentioned earlier, we are still moving ahead with M&A front to establish or expand our presence in Europe.
All right.
[Operator Instructions] There are no further questions at this time. Before I ask Mr. Al-Dor to go ahead with his closing statement, I would like to remind participants that a replay of this call is scheduled to begin in two hours. In the U.S. please call 1-888-295-2634. In Israel please call 03-925-5901 and internationally please call 972-3925-5901.
Mr. Al-Dor, would you like to make your concluding statements?
Thank you to operator and thank you to all the participants for joining us on today's call. Have a good day.
Thank you. This concludes the Sapiens International Corporation's third quarter 2019 results conference call. Thank you for your participation. You may go ahead and disconnect.